| Adrienne Berardi, | |
|
3109 Fairway Dr, 7th Floor, Altoona, PA 16602-4475 | |
| (814) 696-8886 | |
| Not Available |
| Full Name | Adrienne Berardi |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 22 Years |
| Location | 3109 Fairway Dr, Altoona, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023071842 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN272959L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conemaugh Memorial Medical Center | Johnstown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grove City Anesthesia And Pain Management, Pllc | 4688860455 | 61 |
News Archive
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fifth scheduled safety analysis and recommended that the trial continue per the protocol.
Many people who buy their own health insurance could get surprises in the mail this fall: cancellation notices because their current policies aren't up to the basic standards of President Barack Obama's health care law. They, and some small businesses, will have to find replacement plans -; and that has some state insurance officials worried about consumer confusion (Alonso-Zaldivar, 5/29).
Medicure Inc. announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders.
Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.
› Verified 9 days ago
| Entity Name | Anesthesia Associates Of York Pa Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205812260 PECOS PAC ID: 2769394949 Enrollment ID: O20031105000332 |
News Archive
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fifth scheduled safety analysis and recommended that the trial continue per the protocol.
Many people who buy their own health insurance could get surprises in the mail this fall: cancellation notices because their current policies aren't up to the basic standards of President Barack Obama's health care law. They, and some small businesses, will have to find replacement plans -; and that has some state insurance officials worried about consumer confusion (Alonso-Zaldivar, 5/29).
Medicure Inc. announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders.
Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.
› Verified 9 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fifth scheduled safety analysis and recommended that the trial continue per the protocol.
Many people who buy their own health insurance could get surprises in the mail this fall: cancellation notices because their current policies aren't up to the basic standards of President Barack Obama's health care law. They, and some small businesses, will have to find replacement plans -; and that has some state insurance officials worried about consumer confusion (Alonso-Zaldivar, 5/29).
Medicure Inc. announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders.
Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.
› Verified 9 days ago
| Entity Name | 810 Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093880247 PECOS PAC ID: 1355343062 Enrollment ID: O20070209000144 |
News Archive
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fifth scheduled safety analysis and recommended that the trial continue per the protocol.
Many people who buy their own health insurance could get surprises in the mail this fall: cancellation notices because their current policies aren't up to the basic standards of President Barack Obama's health care law. They, and some small businesses, will have to find replacement plans -; and that has some state insurance officials worried about consumer confusion (Alonso-Zaldivar, 5/29).
Medicure Inc. announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders.
Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.
› Verified 9 days ago
| Entity Name | Grove City Anesthesia & Pain Management, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528371556 PECOS PAC ID: 4688860455 Enrollment ID: O20101119000456 |
News Archive
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fifth scheduled safety analysis and recommended that the trial continue per the protocol.
Many people who buy their own health insurance could get surprises in the mail this fall: cancellation notices because their current policies aren't up to the basic standards of President Barack Obama's health care law. They, and some small businesses, will have to find replacement plans -; and that has some state insurance officials worried about consumer confusion (Alonso-Zaldivar, 5/29).
Medicure Inc. announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders.
Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.
› Verified 9 days ago
| Entity Name | Dlp Conemaugh Memorial Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669873881 PECOS PAC ID: 8022238682 Enrollment ID: O20141015000769 |
News Archive
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fifth scheduled safety analysis and recommended that the trial continue per the protocol.
Many people who buy their own health insurance could get surprises in the mail this fall: cancellation notices because their current policies aren't up to the basic standards of President Barack Obama's health care law. They, and some small businesses, will have to find replacement plans -; and that has some state insurance officials worried about consumer confusion (Alonso-Zaldivar, 5/29).
Medicure Inc. announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders.
Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adrienne Berardi, Po Box 108, 7th Floor, Hollidaysburg, PA 16648-0108 Ph: () - | Adrienne Berardi, 3109 Fairway Dr, 7th Floor, Altoona, PA 16602-4475 Ph: (814) 696-8886 |
News Archive
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fifth scheduled safety analysis and recommended that the trial continue per the protocol.
Many people who buy their own health insurance could get surprises in the mail this fall: cancellation notices because their current policies aren't up to the basic standards of President Barack Obama's health care law. They, and some small businesses, will have to find replacement plans -; and that has some state insurance officials worried about consumer confusion (Alonso-Zaldivar, 5/29).
Medicure Inc. announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders.
Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.
› Verified 9 days ago
Edward J Pavlosky Jr., CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 620 Howard Ave, Altoona, PA 16601 Phone: 814-943-5901 Fax: 814-943-3429 | |
Leah L Degol, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 620 Howard Ave, Altoona, PA 16601 Phone: 814-943-5901 Fax: 814-943-3429 | |
Elizabeth Hoenstine, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3109 Fairway Dr, 7th Floor, Altoona, PA 16602 Phone: 814-696-8886 | |
Heather Nicole Ritchey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 620 Howard Ave, Altoona, PA 16601 Phone: 814-943-5901 Fax: 814-943-3429 | |
Dawn K Alexy, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 620 Howard Ave, Altoona, PA 16601 Phone: 814-943-5901 Fax: 814-943-3429 | |
James Noel, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1701 12th Ave Ste G2, 7th Floor, Altoona, PA 16601 Phone: 814-943-5901 |